FDA Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals
Each year, every sponsor of an approved or conditionally approved animal drug application containing an
antimicrobial active ingredient must report to the Food and Drug Administration (FDA) the amount of
each such ingredient in these drug products sold or distributed for use in food-producing animals. FDA
summarizes this information and makes it available to the public in annual summary reports. This
reporting requirement was enacted by Congress in 2008 to assist FDA in its continuing analysis of the
interactions (including antimicrobial resistance), efficacy, and safety of antimicrobials approved for use in
both humans and food-producing animals.
This summary report presents the sales and distribution data for actively marketed antimicrobial drugs
approved for use in food-producing animals by drug class, medical importance, route of administration,
indication, and dispensing status, as well as species-specific estimates, of sales and distribution from 2012
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.